CALGB 80403/ECOG 1206: A randomized phase II study of three standard chemotherapy regimens (ECF, IC, FOLFOX) plus cetuximab in metastatic esophageal and GE junction cancer Meeting Abstract
| Authors: | Enzinger, P. C.; Burtness, B.; Hollis, D.; Niedzwiecki, D.; Ilson, D.; Benson, A. B.; Mayer, R. J.; Goldberg, R. M. |
| Abstract Title: | CALGB 80403/ECOG 1206: A randomized phase II study of three standard chemotherapy regimens (ECF, IC, FOLFOX) plus cetuximab in metastatic esophageal and GE junction cancer |
| Meeting Title: | 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 28 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2010 Jun 4-8 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2010-05-20 |
| Start Page: | 302s |
| Language: | English |
| ACCESSION: | WOS:000208852003476 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2010.28.15_suppl.4006 |
| Notes: | Meeting Abstract: 4006 -- Source: Wos |
